Lake Street Maintains Buy on AEON Biopharma, Raises Price Target to $2
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Lake Street analyst Thomas Flaten maintains AEON Biopharma (AMEX:AEON) with a Buy and raises the price target from $1 to $2.
Lake Street analyst Thomas Flaten maintains AEON Biopharma (AMEX:AEON) with a Buy and raises the price target from $1 to $2.